Release Date: May 2016
Number of Pages: 179
Number of Tables and Figures: 83
Synopsis: A pre-filled syringe is a medical syringe that comes pre-filled with a specific dosage of medication. Representing one of the fastest growing segments of the injectable drug delivery ecosystem, pre-filled syringes offer significant benefits over the traditional ‘vial and syringe’ format, by increasing dosing accuracy, safety and convenience.
In addition, pre-filled syringes also offer a variety of economic benefits to pharmaceutical companies including a reduction in drug overfill and waste, which increases the saleable yield of the API (Active Pharmaceutical Ingredient).
SNS Research estimates that the market for pre-filled syringes will account for nearly $4 Billion in revenue by the end of 2016. Despite challenges relating to drug stability, manufacturing and competition from other drug delivery technologies, the market is poised for significant growth in the coming years.
The “Pre-Filled Syringes Market: 2016 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the pre-filled syringes ecosystem including technology, market drivers, challenges, investment potential, leading therapies, use cases, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for pre-filled syringe unit sales from 2016 through to 2030. The forecasts are further segmented for 4 horizontal submarkets, 10 drug classes, 5 regions and 15 leading countries.
The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
For a sample of the report or any further inquiries please contact email@example.com
Pricing: The report is available for the following price:
Single User License: USD 2,500
Company Wide License (Single Site): USD 3,500
Company Wide License (Global Site): USD 6,500
The report has the following key findings:
The report covers the following topics:
Market forecasts are provided for each of the following submarkets and their subcategories:
Key Questions Answered:
The report provides answers to the following key questions:
List of Companies Mentioned:The following companies and organizations have been reviewed, discussed or mentioned in the report:
AMRI (Albany Molecular Research, Inc.)
Aspen Pharmacare Holdings
BD (Becton, Dickinson and Company)
BSM (Bristol-Myers Squibb)
Datwyler Sealing Solutions
Eli Lilly and Company
EMA (European Medicines Agency)
Fischer Clinical Services
JLS (JSR Life Sciences)
Johnson & Johnson
Laboratorios Farmacéuticos ROVI
LTI (Lyophilization Technology, Inc.)
MedPro Safety Products
Merck and Co.
MGC (MITSUBISHI GAS CHEMICAL)
MHLW (Ministry of Health, Labour and Welfare, Japan)
Ompi (Stevanato Group)
Oval Medical Technologies
Piramal Pharma Solutions
Revolutions Medical Corporation
Roche Holding (F. Hoffmann-La Roche)
SiO2 Medical Products
Sun Pharmaceutical Industries
Takeda Pharmaceutical Company
Teva Pharmaceutical Industries
U.S. FDA (Food and Drug Administration)
Vetter Pharma International
Weigao Group (Shandong Weigao Group Medical Polymer Company)
West Pharmaceutical Services